Within routine clinical practice, white coat hypertension (where blood pressure is persistently higher in the presence of the doctor or nurse but normal outside the medical setting) makes the diagnosis and management of hypertension difficult. There are conflicting data regarding the prevalence and significance of white coat hypertension. This study has used ambulatory blood pressure monitoring to detect the presence of white coat hypertension in 186 patients referred to an out-patient hypertension unit. The presence of white coat hypertension was defined as an average office blood pressure (measured on three occasions over a 2-month period) of Ͼ140/90 mm Hg and an ambulatory awake blood pressure Յ136/86 mm Hg. The prevalence of white coat hypertension in those patients with borderline hypertension (diastolic blood pressure 90-99 mm Hg) and those with mild-to-moderate hypertension (diastolic blood pressure Ն100 mm Hg) was determined. Echocardiography was used to assess left ventricular mass index in
Introduction
Hypertension is common in the general population and, whilst standard blood pressure measurements by cuff are of value in large populations, it is welldocumented that they might be unreliable in individuals. 1 Blood pressure may vary between consecutive measurements over short periods or when measured at different times, often, but not always, resulting in a fall in blood pressure over time. 2 The diagnosis of hypertension and the decision to initiate antihypertensive medication is often difficult given this inherent variability of blood pressure. Clinicians are often presented with patients who initially have raised blood pressure that subsequently falls over a period of time or that varies considerably between visits; patients with 'labile' blood pressure. The reduction in blood pressure over time may be due to specific non-pharmacological measures initiated by the patient such as salt patients with and without white coat hypertension. The prevalence of white coat hypertension in the total group was 23%. However, the prevalence was higher (33%) in those patients with borderline hypertension compared to 9% of those patients with mild-to-moderate hypertension. There was a statistically significant increase in left ventricular mass index in patients with no evidence of white coat hypertension (125 gm/m 2 ) compared to those with white coat hypertension (102 gm/m 2 ). We conclude that, if office blood pressure is used to identify patients with hypertension who may require treatment, some patients will be incorrectly diagnosed and may be treated inappropriately. We recommend that ambulatory blood pressure monitoring is used in the routine assessment of all newly diagnosed hypertensive patients. Furthermore, we recommend echocardiography in patients with borderline hypertension as some will already have an increased left ventricular mass index. restriction, weight reduction or an increase in physical activity.
The additional problem of white coat hypertension, where blood pressure is persistently higher in the presence of the doctor or nurse but normal outside the medical setting, makes the diagnosis and management of hypertension difficult. 3 White coat hypertension has an estimated prevalence ranging from 12% to 53% dependent upon the population studied and definition used. 4, 5 The definition of an elevated office blood pressure is usually taken as у140/90 mm Hg but the definition of a normal out of hospital blood pressure varies. This variation can produce marked differences in the prevalence and significance of the condition. 6 The causes and consequences of the white coat effect have not yet been fully elucidated. Whilst it has been reported that the magnitude of the effect is greater in some patients in the presence of a physician as opposed to a nurse, other studies have shown that nurse measured blood pressure is not a reliable indicator. 7 There are also conflicting data regarding the relationship of the white coat effect to gender and age. 7 Several cross-sectional studies have shown that patients with white coat hyperten-sion have a lower incidence of target organ damage than those who show no white coat effect, but data from other studies is at variance with these findings. 8, 9 There is evidence from a small number of studies that patients with white coat hypertension have a lower risk of cardiovascular events than those without. However, there is also evidence to show that some patients may be in a prehypertensive state and a proportion of patients with white coat hypertension may develop hypertension requiring treatment. 10, 11 The overall aim of the present study was to evaluate the use of ambulatory blood pressure monitoring in the assessment of white coat hypertension in routine clinical practice by: (i) determining the prevalence of white coat hypertension in patients with suspected hypertension referred to an out-patient hypertension clinic, (ii) comparing the prevalence of white coat hypertension, in borderline and mild/moderate hypertension, and (iii) measuring left ventricular mass index in patients with and without white coat hypertension.
Patients and methods
All patients, both male and female, referred to the out-patient hypertension unit, during the period April 1992 to September 1998 who were not currently receiving antihypertensive medication and had not been on antihypertensive medication in the previous year, were included.
Blood pressure was measured in the hypertension unit using a calibrated mercury sphygmomanometer according to British Hypertension Society guidelines on three occasions over a 2-month period. 12 Three measurements of blood pressure were made on each occasion, after 5 min rest, with the subject sitting or lying. At least 1 min was allowed between each measurement and the mean of three measurements was taken as the 'office blood pressure'. The mean blood pressure from the three visits was defined as the average screening blood pressure. Patients with an average blood pressure у140/90 mm Hg underwent baseline investigations.
Baseline investigations
Lifestyle, including smoking, alcohol and exercise, was documented using an investigator completed questionnaire. A clinical history was taken for cardiovascular disease including myocardial infarction, angina, stroke, transient ischaemic attacks, diabetes, peripheral vascular disease and asthma. Drug history, current medication and family history of cardiovascular disease were documented. Demographic data included gender, age (years), height (centimentres) and weight (kilograms).
Ambulatory blood pressure
Non-invasive ambulatory blood pressure was measured using the Medilog Ambulatory Blood Pressure recorder (Medilog ABP) which has previously been shown by the authors to meet the accuracy criteria of the Association for the Advancement of Medical Instrumentation. 13 The Medilog ABP measures blood pressure by the detection of Korotkoff sounds via a transducer taped over the brachial artery. Accuracy to ±6 mm Hg was determined prior to each recording by simultaneous blood pressure measurement, lying down and standing.
The recorder was set to measure blood pressure either at 30-min intervals for 24 h or 15-min intervals from 07.00-18.00 and 30-min intervals thereafter. Patients were instructed to make additional blood pressure measurements using the manual start/quit facility on the recorder if their arm was moving during the measurement. Patients were encouraged to return to their normal daily activities for the duration of the recording. A diary card was used to detail activities during the recording period, in particular the awake and asleep time, and to provide information and advice on the procedure to the subject.
The data from the recorder were transferred to a computer for analysis. Data analysis was undertaken using the commercial software supplied by the manufacturers. Recordings in which 20% or more of the measurements failed were rejected and those patients were encouraged to return for a repeat recording. The mean awake and asleep blood pressures were calculated based on diary times, which has been shown to reflect more accurately patient awake and asleep cycles. 14 The presence of white coat hypertension was defined as a raised office blood pressure, taken as the average screening blood pressure у140/90 mm Hg, and normal ambulatory awake blood pressure р136/86 mm Hg (2 standard deviation upper limit of normal from previously published normal data study).
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Echocardiography
Echocardiography was undertaken with the subject carefully positioned in the partial (30-45°) left lateral decubitus position with the transducer placed in the third to fifth intercostal space. Left ventricular dimensions were measured from the parasternal short axis view just below the level of the mitral valve. Left ventricular end-diastolic internal dimension, interventricular septal thickness and posterior wall thickness in diastole were measured from three cardiac cycles during quiet expiration according to the Penn convention. The Penn convention enddiastolic measurements are taken at the peak of the R wave and exclude the endocardial echoes from the interventricular septal wall, posterior wall and include them in the left ventricular dimension. 16 Recordings were made at 50 mm/sec, with the ECG positioned to allow accurate measurement at the R wave peak. Recordings that were technically difficult, with poor visualisation of the cardiac structures, were not included. Left ventricular mass index was calculated according to method described by Deveraux corrected for body surface area. 16 Left ventricular hypertrophy was defined as a left ventricular mass index Ͼ110 gm/m 2 in females and Ͼ132 gm/m 2 in males. 16 On completion of the baseline investigations, patients attended the out-patient clinic and underwent further investigation for secondary hypertension as clinically indicated. Nonpharmacological advice was given, as required, with regard to smoking, alcohol intake, weight, cholesterol, exercise and salt intake. Those requiring dietary advice were referred to the dietician.
Results
A total of 332 patients were referred during the recruitment period, 103 patients currently being treated for hypertension were excluded. A further 43 patients were excluded as not meeting the office blood pressure criteria (36), failing to attend appointments (5) or intolerance of the blood pressure recorder (2) . The remaining 186 patients, 95 males and 91 females, comprised the study group.
The majority (93%) of patients had never received antihypertensive medication and in the 7% who had previously received therapy none had done so in the previous 12 months. Three patients had a history of cardiovascular disease (one myocardial infarction, two transient ischaemia attacks). No patients had any ECG evidence of atrial fibrillation. The mean age of the group was 46 (range 18-71) years, height 1.7 (range 1.42-1.93) metres and weight 78 (45-152) kilograms.
The baseline mean screening blood pressure was higher 161/101 mm Hg than the ambulatory awake blood pressure 145/91 mm Hg of the group. These data, together with the data for asleep and overall ambulatory blood pressure, are shown in Table 1 . Average screening systolic blood pressure was higher than ambulatory awake blood pressure in 164 (88%) and average screening diastolic blood pressure was higher in 169 patients (91%). Using the definition described in the methods section 42 patients had white coat hypertension (prevalence 23%).
The patients were divided into two groups: borderline hypertension (defined as an average screening diastolic blood pressure 90-99 mm Hg) and mild/moderate hypertension (у100 mm Hg). Ninetyeight (53%) of patients were classified as borderline hypertensives and 88 (47%) patients as mild/moderate hypertensives. Comparison of the groups showed an increase in prevalence of white coat hypertension in the borderline hypertensives 32 (33%) compared to 8 (9%) of the mild/ moderate hypertensives.
The total group was then divided into those with white coat hypertension (n = 42) and those without (n = 44) and the groups compared. The groups were (10) similar in age (45 vs 48 years, P = NS) but the white coat hypertensive group had a higher proportion of females (55% vs 47%, P = Ͻ0.05) Both screening and ambulatory blood pressures were significantly lower in the group with white coat hypertension, as shown in Figure 1 . Echocardiography was available in 168 patients (in 18 (10%) patients technically acceptable recordings could not be obtained). Left ventricular diastolic dimension was similar in both groups. The group with white coat hypertension had a lower interventricular septal thickness, posterior wall thickness and left ventricular mass index than those where white coat hypertension was absent and these comparisons reached statistical significance (P Ͻ 0.05). These results are shown in Table 2 .
Only eight patients with white coat hypertension had an increase in interventricular septal thickness Ͼ1.2 cm (18%) compared with 55 patients (38%) in the group who showed no white coat effect. Left ventricular mass index was increased (females Ͼ110 and males Ͼ132 gm/m 2 ) in 9% of the white coat group compared to 44% in the non-white coat group.
Discussion
Within routine clinical practice it is important to identify patients with a raised blood pressure in the surgery and a normal blood pressure at other times as these patients are likely to be managed differently to those with sustained blood pressure elevation. These patients essentially have office hypertension and ambulatory normotension. The term 'white coat hypertension' has traditionally been used to describe this scenario where patients exhibit an acute elevation of blood pressure that is induced by the presence of a doctor and this term is still widely used not only by hospital physicians and general practitioners but also by patients themselves. However, more recently the terms 'isolated clinic hypertension' or 'isolated office hypertension' have been used to describe these patients. This term takes account of the fact that it is not exclusively the white coat of the physician which causes the difference in office to daytime blood pressure but that other factors including daytime activity are involved. 4, 17, 18 Ambulatory blood pressure monitoring is a reliable, non-invasive technique to measure out-of-hospital blood pressure and many general practices now undertake it within their own practice or by referral to specialist centres.
White-coat hypertension is common with a prevalence of 23% in this group of patients, which is similar to that found in other studies in different populations, but it is important to recognise differences between reported studies. 4, 5 These differences may relate to variations in the populations studied or may reflect the differing criteria used to define white coat hypertension, including cuff-off points and methods of calculation of both office and ambulatory blood pressure. 6 The prevalence of white coat hypertension in patients with borderline hypertension was, perhaps not unsurprisingly, found to be higher (33%) than in those with mild/moderate hypertension. Whilst the prevalence of borderline hypertension varies dependent upon the definition used (some studies using blood pressure alone, others including evidence of target organ damage), there are convincing data to show that the prevalence increases with age and may be as high as 40% by the age of 60. 19 There is also evidence to suggest that the level of blood pressure as a juvenile predicts future blood pressure. Therefore, those starting with a blood pressure level at the higher end of the normal range are more likely to progress to borderline hypertension. 20 Patients with borderline hypertension will be common in general practice and the use of 24-h blood pressure monitoring to identify those subjects with a normal out-of-hospital blood pressure who may not initially require antihypertensive medication but will require regular follow-up is important. It is recognised that the definition of a 'normal out-of-hospital blood pressure' is still subject to some debate as there are no large-scale prospective epidemiological studies available.
White coat hypertension has implications for the management and treatment of patients with hypertension, and also cost implications, which need further work. It is, however, likely that the measurement of out-of-hospital blood pressure using ambulatory blood pressure monitoring will become commonplace. 21 Several cross-sectional studies have shown that patients with white coat hypertension have a lower incidence of target organ damage, as has been shown in the present study, but there are other studies which have refuted this. 8, 22 There are few long-term studies of patients with white coat hypertension, but the evidence from two studies suggests that patients with a lower ambulatory blood pressure have a lower risk of subsequent fatal or non-fatal cardiovascular events than those with more elevated ambulatory blood pressure, and have a good prognosis similar to those with normotension. 10, 23 However, data from the Cornell study indicated that white coat hypertension is associated with a risk between that of normotension and hypertension, and a study by Alderman et al found that hypertensive patients with a blood pressure higher when taken by a doctor than a nurse had a higher risk of myocardial infarction during a 14-year follow-up period. 24, 25 There is also evidence that treating patients with white coat hypertension, before they have developed hypertension on ambulatory recording, may not confer benefit but result in the overtreatment of hypertension. 26 Studies looking at the response of white coat hypertensives to laboratory stresses have demonstrated that these patients do not score higher on reactivity scales measuring anger or anxiety and it has been suggested that the white coat response is a learned condition response. 27 Fear might originally induce an increase in blood pressure and subsequently the awareness of hypertension determine an increased sympathetic arousal at each visit, and this response may be benign. In others, it may be an alarm response and it may occur in response to everyday stresses the patient encounters. 28 This study has demonstrated that some patients with only small elevations of blood pressure already have evidence of left ventricular hypertrophy. Left ventricular hypertrophy is an important independent risk factor for cardiovascular disease in both normotensive and hypertensive populations and risk increases progressively with the degree of left ventricular hypertrophy. 29 When detected by echocardiography, left ventricular hypertrophy has been shown to have a prevalence of 16% in males and 21% in females, the prevalence increasing with age. Some studies have shown an independent increase in left ventricular mass with age from 8% in males under 30 years to 33% in those age 70 years or more; similarly for females the increase is from 5% to 49%. 30 However, it is recognised the lower left ventricular mass index in those patients with 'white coat hypertension' may reflect differences in blood pressure levels, rather than the white coat effect per se.
Echocardiography is a technique that allows the reliable, non-invasive estimation of left ventricular mass. Previously, most physicians have relied on the ECG to detect the presence of LVH. However, the ECG has been found to be specific but insensitive in the detection of LVH compared to echocardiography. 31 The findings from this study show that a small proportion of patients with white coat hypertension may have echocardiographic left ventricular hypertrophy (9%). In view of the implications of the presence of left ventricular hypertrophy, 32 echocardiography should be considered in patients with white coat hypertension to detect the presence or absence of left ventricular hypertrophy and thus target treatment at patients with documented target organ damage. It has been suggested that in these circumstances a limited echocardiographic study would be appropriate. 33 Whether these patients with 'white coat hypertension' require treatment at diagnosis remains a clinical dilemma and there is continuing debate as to whether it is an innocent phenomenon or whether it carries an increased cardiovascular burden. 34 We would recommend that these patients have a full assessment of cardiovascular risk and, in line with current guidelines, those at high risk or with documented target organ damage should be considered for treatment. 35 Guidelines from New Zealand have recommended treating those patients with uncomplicated mild hypertension and a cardiovascular event risk of 2% per year (20% over 10 years). 36 Those patients at low cardiovascular risk should be followed up on a regular basis and at present we would suggest that their blood pressure should be measured at least every 6 months by the practice nurse. There is insufficient evidence to support precise guidelines for the follow-up of these patients but our current practice is to re-assess cardiovascular risk annually and consider a further 24-h blood pressure recording in those patients whose office blood pressure has risen.
Conclusion
If office blood pressure alone is used to identify patients with hypertension it will result in some patients being incorrectly diagnosed and treated inappropriately. It is recommended that 24-h ambulatory blood pressure monitoring be used in the routine assessment of all newly diagnosed hypertensive patients. Furthermore, limited echocardiography should also be considered as some patients with only borderline hypertension will already have an increased left ventricular mass.
